These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31043342)

  • 1. AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis Pigmentosa.
    McDougald DS; Papp TE; Zezulin AU; Zhou S; Bennett J
    Mol Ther; 2019 Jul; 27(7):1313-1326. PubMed ID: 31043342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-mediated gene replacement, either alone or in combination with physical and pharmacological agents, results in partial and transient protection from photoreceptor degeneration associated with betaPDE deficiency.
    Allocca M; Manfredi A; Iodice C; Di Vicino U; Auricchio A
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5713-9. PubMed ID: 21273543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors.
    Tan MH; Smith AJ; Pawlyk B; Xu X; Liu X; Bainbridge JB; Basche M; McIntosh J; Tran HV; Nathwani A; Li T; Ali RR
    Hum Mol Genet; 2009 Jun; 18(12):2099-114. PubMed ID: 19299492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa.
    Tosi J; Sancho-Pelluz J; Davis RJ; Hsu CW; Wolpert KV; Sengillo JD; Lin CS; Tsang SH
    Exp Biol Med (Maywood); 2011 Oct; 236(10):1211-7. PubMed ID: 21885480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina.
    Jung G; Sun J; Petrowitz B; Riecken K; Kruszewski K; Jankowiak W; Kunst F; Skevas C; Richard G; Fehse B; Bartsch U
    Stem Cells Transl Med; 2013 Dec; 2(12):1001-10. PubMed ID: 24167317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.
    Zhang L; Du J; Justus S; Hsu CW; Bonet-Ponce L; Wu WH; Tsai YT; Wu WP; Jia Y; Duong JK; Mahajan VB; Lin CS; Wang S; Hurley JB; Tsang SH
    J Clin Invest; 2016 Dec; 126(12):4659-4673. PubMed ID: 27841758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model.
    Kajtna J; Tsang SH; Koch SF
    Cell Mol Life Sci; 2022 Feb; 79(3):148. PubMed ID: 35195763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
    Zhang L; Chen C; Fu J; Lilley B; Berlinicke C; Hansen B; Ding D; Wang G; Wang T; Shou D; Ye Y; Mulligan T; Emmerich K; Saxena MT; Hall KR; Sharrock AV; Brandon C; Park H; Kam TI; Dawson VL; Dawson TM; Shim JS; Hanes J; Ji H; Liu JO; Qian J; Ackerley DF; Rohrer B; Zack DJ; Mumm JS
    Elife; 2021 Jun; 10():. PubMed ID: 34184634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa.
    Wert KJ; Sancho-Pelluz J; Tsang SH
    Hum Mol Genet; 2014 Jan; 23(2):514-23. PubMed ID: 24101599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa.
    Dalkara D; Kolstad KD; Guerin KI; Hoffmann NV; Visel M; Klimczak RR; Schaffer DV; Flannery JG
    Mol Ther; 2011 Sep; 19(9):1602-8. PubMed ID: 21522134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental enrichment extends photoreceptor survival and visual function in a mouse model of retinitis pigmentosa.
    Barone I; Novelli E; Piano I; Gargini C; Strettoi E
    PLoS One; 2012; 7(11):e50726. PubMed ID: 23209820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa.
    Wert KJ; Davis RJ; Sancho-Pelluz J; Nishina PM; Tsang SH
    Hum Mol Genet; 2013 Feb; 22(3):558-67. PubMed ID: 23108158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.
    Zhang X; Girardot PE; Sellers JT; Li Y; Wang J; Chrenek MA; Wu W; Skelton H; Nickerson JM; Pardue MT; Boatright JH
    Mol Vis; 2019; 25():462-476. PubMed ID: 31523123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive Activation Mutant mTOR Promote Cone Survival in Retinitis Pigmentosa Mice.
    Rajala A; Wang Y; Rajala RVS
    Adv Exp Med Biol; 2018; 1074():491-497. PubMed ID: 29721981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
    Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The manner of decay of genetically defective EYS gene transcripts in photoreceptor-directed fibroblasts derived from retinitis pigmentosa patients depends on the type of mutation.
    Seko Y; Iwanami M; Miyamoto-Matsui K; Takita S; Aoi N; Umezawa A; Kato S
    Stem Cell Res Ther; 2018 Oct; 9(1):279. PubMed ID: 30359287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: the history and role of naturally occurring mouse models with Pde6b mutations.
    Han J; Dinculescu A; Dai X; Du W; Smith WC; Pang J
    Mol Vis; 2013 Dec; 19():2579-89. PubMed ID: 24367157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
    Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
    Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal protein S6 kinase 1 promotes the survival of photoreceptors in retinitis pigmentosa.
    Lin B; Xiong G; Yang W
    Cell Death Dis; 2018 Nov; 9(12):1141. PubMed ID: 30442943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing Gene Therapy for PDE6A Retinitis Pigmentosa.
    Petersen-Jones SM; Occelli LM; Biel M; Michalakis S
    Adv Exp Med Biol; 2019; 1185():103-107. PubMed ID: 31884596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.